Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Tanda

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Journal of Endocrinological Investigation|January 30, 2007
Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep tryingL Bartalena, M L Tanda
Journal of Endocrinological Investigation|June 24, 2006
Currently available somatostatin analogs are not good for Graves' orbitopathyM L Tanda, L Bartalena
Journal of Endocrinological Investigation|March 31, 2021
Graves' orbitopathy in Natalie Frank's oeuvreM L Tanda, F Trimarchi
Journal of Endocrinological Investigation|July 3, 2020
Liraglutide is an effective drug for the treatment of obesity also in real lifeE Piantanida, D Gallo, M L Tanda
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Predicting the Risk of Graves Disease Relapse: Commentary on "Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease"D Gallo, M L Tanda, E Piantanida
Journal of Endocrinological Investigation|June 4, 2020
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case reportS Ippolito, F Dentali, M L Tanda
Journal of Endocrinological Investigation|July 6, 2004
The role of somatostatin analogs in the management of Graves' ophthalmopathyL Bartalena, M L Tanda, E Piantanida, et al.
Journal of Endocrinological Investigation|April 11, 2022
Teprotumumab for Graves' orbitopathy and ototoxicity: moving problems from eyes to ears?L Bartalena, M Marinò, C Marcocci, et al.
Journal of Endocrinological Investigation|May 28, 2022
Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicityL Bartalena, C Marcocci, M L Tanda, et al.
Journal of Endocrinological Investigation|July 2, 2008
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?L Bartalena, C Marcocci, A Lai, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Journal of Endocrinological Investigation|January 30, 2007
Immunotherapy for Graves' orbitopathy: easy enthusiasm, but let's keep tryingL Bartalena, M L Tanda
Journal of Endocrinological Investigation|June 24, 2006
Currently available somatostatin analogs are not good for Graves' orbitopathyM L Tanda, L Bartalena
Journal of Endocrinological Investigation|March 31, 2021
Graves' orbitopathy in Natalie Frank's oeuvreM L Tanda, F Trimarchi
Journal of Endocrinological Investigation|July 3, 2020
Liraglutide is an effective drug for the treatment of obesity also in real lifeE Piantanida, D Gallo, M L Tanda
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|January 20, 2021
Predicting the Risk of Graves Disease Relapse: Commentary on "Thyroid Peroxidase Antibody Positivity is Associated with Relapse-Free Survival Following Antithyroid Drug Treatment for Graves Disease"D Gallo, M L Tanda, E Piantanida
Journal of Endocrinological Investigation|June 4, 2020
SARS-CoV-2: a potential trigger for subacute thyroiditis? Insights from a case reportS Ippolito, F Dentali, M L Tanda
Journal of Endocrinological Investigation|July 6, 2004
The role of somatostatin analogs in the management of Graves' ophthalmopathyL Bartalena, M L Tanda, E Piantanida, et al.
Journal of Endocrinological Investigation|April 11, 2022
Teprotumumab for Graves' orbitopathy and ototoxicity: moving problems from eyes to ears?L Bartalena, M Marinò, C Marcocci, et al.
Journal of Endocrinological Investigation|May 28, 2022
Reply to Letter to the Editor by Dr. Terry J. Smith regarding teprotumumab and ototoxicityL Bartalena, C Marcocci, M L Tanda, et al.
Journal of Endocrinological Investigation|July 2, 2008
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?L Bartalena, C Marcocci, A Lai, et al.
Pageof 6